Calliditas Therapeutics AB KOL Webinar Transcript
Good afternoon, and welcome to the Calliditas Therapeutics fireside chat. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Calliditas website following the conclusion of the event. I'd now like to turn the call over to Renee Lucander, Chief Executive Officer of Calliditas Therapeutics. Please go ahead, Renee.
()-
Thank you. Welcome, everybody, and thank you for joining this presentation by Dr. Richard Lafayette on the treatment landscape of IgA nephropathy and recently published data in this space.
So Dr. Lafayette is a Professor of Medicine on Nephrology at the Stanford University Medical Center. He has, as many of you know, a very impressive background in the area nephrology and a long-standing interest in glomera diseases with a focus on IgA nephropathy. He's a Founder and Director of the Stanford Glomerular Disease Center and its fellowship training program. He has over 25 years of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
